In the French arm of the ERSPC (European Randomized Study of Prostate Cancer Screening), AUC for detecting csPCa increased from 0.77 for a basic model (age, total PSA, and DRE) to 0.87 after adding four‐kallikrein panel.16 This evidence concerns the gene KLK4 and prostate carcinoma.